Genotypic and Phenotypic Modifications of Neisseria meningitidis after an Accidental Human Passage by Omer, Hélène et al.
Genotypic and Phenotypic Modifications of Neisseria
meningitidis after an Accidental Human Passage
He ´le `ne Omer
1,2, Graham Rose
3, Keith A. Jolley
4, Eric Frapy
1,2, Jean-Ralph Zahar
1,5, Martin C. J. Maiden
4,
Stephen D. Bentley
3, Colin R. Tinsley
6, Xavier Nassif
1,2,5*, Emmanuelle Bille
1,2,5
1INSERM U1002, Paris, France, 2Universite ´ Paris Descartes, Faculte ´ de Me ´decine Necker-Enfants Malades, Paris, France, 3The Wellcome Trust Sanger Institute, Hinxton,
Cambridge, United Kingdom, 4Department of Zoology, University of Oxford, Oxford, United Kingdom, 5Assistance publique - Ho ˆpitaux de Paris, Laboratoire de
Microbiologie, Ho ˆpital Necker-Enfants Malades, Paris, France, 6Genetic regulation and biofilms, UMR Micalis 1319, INRA/AGROPARITECH, Thiverval-Grignon, France
Abstract
A scientist in our laboratory was accidentally infected while working with Z5463, a Neisseria meningitidis serogroup A strain.
She developed severe symptoms (fever, meningism, purpuric lesions) that fortunately evolved with antibiotic treatment to
complete recovery. Pulse-field gel electrophoresis confirmed that the isolate obtained from the blood culture (Z5463BC)
was identical to Z5463, more precisely to a fourth subculture of this strain used the week before the contamination
(Z5463PI). In order to get some insights into genomic modifications that can occur in vivo, we sequenced these three
isolates. All the strains contained a mutated mutS allele and therefore displayed an hypermutator phenotype, consistent
with the high number of mutations (SNP, Single Nucleotide Polymorphism) detected in the three strains. By comparing the
number of SNP in all three isolates and knowing the number of passages between Z5463 and Z5463PI, we concluded that
around 25 bacterial divisions occurred in the human body. As expected, the in vivo passage is responsible for several
modifications of phase variable genes. This genomic study has been completed by transcriptomic and phenotypic studies,
showing that the blood strain used a different haemoglobin-linked iron receptor (HpuA/B) than the parental strains (HmbR).
Different pilin variants were found after the in vivo passage, which expressed different properties of adhesion. Furthermore
the deletion of one gene involved in LOS biosynthesis (lgtB) results in Z5463BC expressing a different LOS than the L9
immunotype of Z2491. The in vivo passage, despite the small numbers of divisions, permits the selection of numerous
genomic modifications that may account for the high capacity of the strain to disseminate.
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Introduction
Neisseria meningitidis (Nm) is primarily an asymptomatic coloniser
of the human nasopharynx of about 10% of the population [1].
But it is better known as the causative agent of meningococcal
disease, which kills an estimated 50,000 individuals worldwide
annually [2]. In these cases, Nm disseminate from the nasopharynx
into the bloodstream where they can survive and divide giving a
bacteraemia, which can evolve to meningitis or septicaemia. The
meningococcal population is classified in different phylogenetic
groups, the clonal complexes, defined by multilocus sequence
typing (MLST; [3]). The large majority of disease is caused by a
small number of these groups, which are hence called hypervir-
ulent clonal complexes [3]. In industrialised countries, most
neisserial disease is caused by serogroup B and C strains whereas
serious epidemics occur in the sub-Saharan part of Africa due to
serogroup A strains [4]. It is worth noticing the emergence of the
serogroups X, W135 and Y worldwide.
The reasons for the occurrence of disease in some individuals
but not in others remain unclear, even if both human and bacterial
factors have been implicated in the different possible outcome of
the infection. The most important human factors to counter
neisserial disease are the bactericidal antibodies [5,6] and the
complement system [7]. Among the bacterial factors, the
protective polysaccharide capsule is necessary for survival in the
bloodstream and subsequent disease, even if some acapsulated
bacteria have recently been isolated from patients [8,9]. Several
other bacterial structures are important for bacterial pathogenesis:
the endotoxin lipooligosaccharide (LOS; [10]), the type IV pili
[11], the recently described proteins capable of binding comple-
ment factor H (FhbP, NspA) [12,13], and the iron acquisition
systems from transferrin and lactoferrin (transferrin binding
protein TbpA and TbpB; [14]) or haemoglobin and haptoglobin
(HpuAB and HmbR) [15–17]. By comparing the genomes of
meningococci belonging to clonal complexes designated as having
higher or lower invasive potential [18,19], a prophage was shown
to be present at higher frequency in strains responsible for invasive
disease. This genetic element was designated MDA for Meningo-
coccal Disease-Associated island [20]. Subsequent analyses have
demonstrated that a fraction of the invasiveness of strains
belonging to hyperinvasive clonal complexes is correlated with
the presence of the prophage, and showed an association with
virulence in young adults but not in children less than two years of
age [21]. However the mechanism by which this prophage
increases invasiveness remain unclear. Beside the insertion of this
prophage, no known genomic island has been associated with
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complexes that are not hyperinvasive have all the necessary
attributes to survive in the extracellular fluids. Furthermore,
established or potential virulence factors are not universally
present in meningococci isolated from invasive disease.
The ability of the bacteria to adapt to changing environments is
key for invasiveness. Some of the neisserial virulence attributes are
tightly controlled at the transcriptional level by regulators such as
the Fur protein responding to variations in iron concentration
[22], or by two component-systems such as PhoP(MisR)/
PhoQ(MisS) [23]. In addition, several of the bacterial attributes
required for meningococcal colonization and/or dissemination are
subject to phase and/or antigenic variation [24–29], thus allowing
the bacteria to rapidly adapt to its environment. The genomic
modifications responsible for phase variation occur at a higher
frequency in hypermutator strains defective in post-replication
DNA mismatch correction, most often due to mutations in the
repair genes mutS, mutL or mutY. Some pathogenic strains from
epidemics have been shown to display this kind of hypermutator
phenotype especially during the African epidemics due to
serogroup A strains [30,31].
As for many human specific diseases, the difficulty of
reproducing the human disease in animal models has hampered
the identification of the neisserial attributes required for
invasiveness. Several studies have reported clinical laboratory
acquired meningococcemia [32–38]. These reports focussed on
tracing the infecting strain amongst those manipulated by the
patient during the weeks before the disease. Here we took
advantage of a laboratory contamination responsible for an
invasive meningococcemia to compare the genome of the
bloodstream isolate with that of the contaminating isolate. The
bloodstream isolate differed from the infecting strain mostly due to
phase variation of virulence genes allowing the expression of
different phenotypes. Amongst these phenotypes are the ability of
the strain to use different receptors to get iron from the host
haemoglobin, the expression of a different LOS to evade the host
immune system and the presence of different pilin variants
conferring different properties on human cells. Our data showed
that, despite the small number of in vivo generations between the
contaminating and the bloodstream isolates, limited genomic
modifications have been selected that may account for the ability
of the strain to increase its invasiveness.
Materials and Methods
Clinical case
In November 2007, a 32 years-old female working in our
laboratory was admitted in the infectious diseases unit at the
Necker-Enfants Malades Hospital (Paris, France) with fever,
meningism and small purpuric lesions. The night before
admission, she complained of fever, chills and headache. Upon
admission, she was alert and orientated but suffered from severe
headache and was febrile at 39uC. Her physical examination
revealed nuchal rigidity with small purpuric lesions on all the four
limbs. Antibiotic treatment (intravenous ceftriaxone 50 mg/kg/
day) was administered just after a blood culture sampling. A
lumbar puncture revealed a clear cerebrospinal fluid (CSF). CSF
protein was 0.84 g/L, glucose 2.6 mmol/L with blood glucose at
5.6 mmol/L. CSF contained 1,190/mm
3 red blood cells and 90/
mm
3 white blood cells (90% PNN) and no germ was detectable on
Gram stain. A non-contrast CT-scan was normal. The next day,
blood culture was positive for serogroup A meningococci.
Ceftriaxone was carried on for 7 days. The patient state improved
rapidly and she was discharged on day 5 without sequellae.
The patient had no apparent immune defect (notably, no
complement anomaly was detected) or known predisposing factor
for meningococcal disease. She had been working at the bench
with Nm for five years and had therefore been vaccinated in
October 2002 with the meningococcal A + C polyosidic vaccine
(Sanofi Pasteur MSD). This vaccine is efficient for 3 years; no
booster had been administered. A thorough investigation of the
research practices and the material were performed and revealed
that the accidental contamination was due to the malfunction of a
hood.
According to the french law and considering that this study was
not an experimental study in humans, this study did not need
approval by an ethic committee. Written informed consent from
the patient was obtained to perform this study and to publish the
data as presented in this manuscript.
Bacterial strains and growth medium
Because Nm Z2491 (formerly C751), whose genome has been
completed by the Sanger centre [25], is not transformable, we are
routinely working with Z5463 (formerly C396). Z2491 and Z5463
were isolated during the same epidemic in The Gambia in 1983
[39]. Z5463 is a naturally transformable serogroup A strain
belonging to the same sequence type as strain Z2491, i.e. ST-4
[40], subgroup IV-1, expressing OpaA and OpaC. This strain was
stored frozen at 280uC and was used at that time to explore the
role of the MDA phage in invasiveness. The person who was
contaminated worked on isolating spontaneous variants of Z5463
that expressed high levels of the MDA phage proteins (see below).
The week before the contamination she was working with such a
derivative of Z5463 designated Z5463PI (for Plate Isolate). Four
passages took place between the frozen stock of Z5463 and the
frozen stock of Z5463PI. The strain isolated from the bloodstream
was designated Z5463BC (for Blood Culture). The blood culture
was directly frozen at the hospital without further subculture. In
order to avoid as much as possible secondary variations, all the
experiments have been carried out on direct cultures of frozen
stocks.
Neisseria were routinely grown at 37uCi n5 %C O 2 in GC-liquid
medium or on GC medium base (Difco) containing Kellogg’s
supplements [41]. When needed, antibiotics were used at a
concentration of 5 mg/mL of chloramphenicol, 200 mg/mL of
kanamycin and 75 mg/mL of spectinomycin. The frequency of
occurrence of rifampicin resistance mutants was obtained by
plating bacteria onto GCB agar plates supplemented or not with
30 mg/mL of rifampicin.
To test the ability of Nm to chelate iron from haemoglobin, a
single colony taken from an overnight growth on agar plate was
resuspended in liquid GCB and plated onto GCB agar
supplemented with 12 mM ferric nitrate or 50 mM deferoxamine
mesylate (Sigma). The medium was allowed to evaporate for
approximately 15 min and discs containing either 50 mg of ferric
nitrate or 100 mg of human or bovine haemoglobin (Sigma) were
placed on the plate.
Pulsed field gel electrophoresis and detection of the
MDA phage by Southern-blot
Bacteria were suspended in PBS - 7% sucrose to an OD600 of
1, mixed with an equal volume of 2% Agar Low-Melting-Point
and child in a plastic mould. Once the plugs were solid, bacterial
proteins were lysed by the addition of EDTA (0.5 M), SDS 1%
and proteinase K (0.5 mg/mL) at 56uC for 24 h. The reaction was
stopped by the addition of PMSF and the plugs were washed with
TE. The plugs were equilibrated in 300 mL of digestion buffer for
1 h before a 24 h incubation at 37uC with 20 units of BglII (New
Modifications of Meningococcus after Human Passage
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Electrophoresis was performed on a Chef-mapper (Bio-Rad) at
14uC, at 6 V/cm with pulses ramping from 0.5 to 30 sec over 20 h
with an angle of 120u. The gel was stained with ethidium bromide
and photographed under UV light.
DNA was transferred from the gel to a nylon membrane Hybond
N+ (Amersham) by capillary action and fixed by a 5 min exposition
to UV light. The membrane was then hybridized to c-
33Pd C T P
labelled PCR product of NMA1792 [20] to detect the MDA
insertions. Bound probes were detected by exposure ofthe membrane
overnight at 220uC between intensificating screens. The screen was
read on a Storm 840 (GE Healthcare) with a 50 pixels resolution.
Search for chromosomal rearrangements induced by the
MDA phage
We have previously described that the MDA prophage is
inserted in dRS3 repeats [20], more precisely in some target dRS3
sequences (consensus dRS3/Nf1 sequence: ATTCCCgcCTgcgc-
GGGAAT; [42]). These sequences are present 291 times in the
genome of Z2491 (672 dRS3 sequences in total) and assembled in
89 ‘‘neisserial intergenic mosaic elements’’ (NIME) that corre-
spond to dRS3 sequences flanked by RS sequences [25]. To detect
putative chromosomal rearrangements induced by the MDA, we
designed PCR primers to discriminate each of these 89 NIME
(Table S1). Total DNA was extracted using the Wizard Genomic
DNA purification kit (Promega) and PCR was performed using
Ex-Taq (Takara) and pairs of the above primers. PCR were
performed to amplify independently each NIME. The presence
and size of every band was assessed to verify that the chromosomal
arrangement was according to the known genome sequence. To
identify possible rearrangement occurring between two NIME
arrays, each primer specific of a NIME was tested against all the
other primers.
Mapping of the MDA insertions
To precisely map the phage chromosomal insertions, Ligation-
Mediated PCR were performed as described by Pelicic and co-
workers [43]. Total DNA was digested with NaeIo rMboI (New
England Biolabs). The DNA was ligated with the linkers LMP1,
LMP2 or LMP3. Primers corresponding to the MDA (MDAbe-
ginR and MDAendF) were used with the appropriate linker to
amplify and sequence the sites of insertion of the MDA (Table S1).
Detection of the production of the MDA phage
The production of MDA phage was assessed by the detection of
circular form of the MDA DNA by PCR, using MDAbeginR and
MDAendF as primers (Table S1).
A bioinformatic analysis of the ORFs encoded by the MDA
prophage identified NMA1796 as the putative major capsid
protein. A polyclonal anti-NMA1796 antibody was raised and
purified using the following peptide: H2N-CINFLKDMGKV-
GTD-COOH. The analysis of the production of phage proteins
was performed by immunoblot directly on colonies after transfer
onto a nitrocellulose filter. Briefly, isolated colonies grown
overnight were transferred to a reinforced nitrocellulose mem-
brane (0.2 mm pore size, Optitran BA-S 83) and allowed to air
dry. Non-specific binding sites were blocked for 1 h with PBS - 5%
milk. Filters were washed and incubated for 1 h with a 10,000-fold
dilution of antiserum raised against the peptide of NMA1796.
Excess antibody was removed by washes in PBS-Tween and the
filters were incubated for 1 h with an anti-rabbit IgG-peroxydase
antibody (Sigma). After washing, bound antibodies were detected
by chemiluminescence using ECL plus reagents (GE Healthcare).
Engineering of Nm mutants
A mutation in hpuA (DhpuA) was engineered by introducing the
chloramphenicol resistance cassette in the gene. The hmbR
mutation (DhmbR, spectinomycin resistant) and the pilE mutation
(DpilE, kanamycin resistant) have been previously described
([44,45], respectively). These mutations were transformed into
Z5463, Z5463PI or Z5463BC as needed. When necessary, mutS
from either Z5463 or Z2491 was cloned and a spectinomycin
resistance cassette was inserted after the gene, leaving a
downstream intergenic sequence at the 39-end, thus allowing to
perform the allelic exchange. All mutants were checked using PCR
amplification and sequencing. Primers are listed in Table S1.
LOS extraction
Meningococcal LOS was purified from total cell extracts of
overnight plate by a proteinase K treatment as previously
described [45]. The size differences were observed on a 16%
Tricine SDS-PAGE gel by silver staining.
RNA extraction and transcriptomic studies
RNA was extracted by a Trizol chloroform method before using
the RNeasy clean up protocol from Qiagen. DNA was removed by
addition of Turbo DNaseTM (Ambion). The complete removal of
DNA was assessed by the absence of signal in a PCR run.
Equal amounts of RNAs of each strain were labeled
differentially using Cy3-dCTP and Cy5-dCTP (Amersham
Pharmacia) during a first reverse-transcriptase step using the
Superscript II RNase H2 reverse transcriptase (Life Technologies)
and a balanced mixture (20 pmol each) of C-terminal primers
specific for each gene present on the microarrays. The
differentially labeled cDNA were combined and hybridized
overnight at 42uC to the Neisseria chips (Eurogentec), composed
of overlapping 40-mer oligonucleotides covering the entire
genome of strain Z2491. After washing, arrays were scanned
using the Axon 4000B Scanner (Genepix Pro) with the Limma
Bioconductor program. The fluorescence data were normalized
and the fluorescence ratios were calculated from the normalized
values. Each experiment was repeated three times in swap dye,
genes were referred as being differentially transcribed when a
minimal 2-fold deregulation on average in more than 50% of the
independent experiments was observed.
Cell adhesion and signalisation assays
The immortalized human brain microvessel endothelial cell line
(hCMEC/D3) [46] was grown and infected as described by
Coureuil and co-workers [47]. Briefly the cells were infected at a
multiplicity of infection of 100. For cell adhesion assays, after
extensive washing to remove unbound Nm, the human cells were
scraped from the wells, and the number of cell associated CFUs
determined.
When needed, immunofluorescence assays were performed
after 2 h of infection. Antibodies and markers used included:
rabbit anti-Ezrin polyclonal antibody (1:1,000), generously pro-
vided by Dr. P. Mangeat (CNRS, UMR5539, Montpellier,
France) and Alexa-488 conjugated anti-rabbit IgG secondary
antibody (1:200, Invitrogen); Alexa-546 conjugated phalloidin and
DAPI (0.5 mg/mL, Sigma).
Genome sequencing and analysis
Genome sequencing, data collection and first analyses were
performed at the Wellcome Trust Sanger Institute. Genome
sequences were generated by whole-genome shotgun sequencing
(454 Life Science, Inc.) of Z5463, Z5463PI and Z5463BC giving a
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(Solexa) of Z5463, Z5463PI and Z5463BC giving a 154-, 84- and
78-fold coverage. The genomes were assembled using MAQ
(Mapping and Assembly with Qualities; [48]) with Z2491
sequence [25] as the assembly reference genome. The sequences
are deposited in the PubMLST website ([Neisseria
PubMLST:17881–17883]).
All the following analyses were made using Z2491 sequence as
the reference genome. The MAQ program was used to detect and
extract all the Single Nucleotide Polymorphism (SNP) between the
reference and each strain. The SNP were extracted, automatically
validated and then assessed manually, when we were unable to
conclude the region was again sequenced (see below). For broader
genome rearrangement, we used the programs ABACAS [49] and
Artemis [50]. The presence of numerous repeats made it difficult
to discriminate some contig layouts. Primers discriminating
between every set of NIME were used as previously described.
We focused on these repeats because (i) they were often associated
with inconclusive layouts, (ii) they have already been suggested to
allow genetic recombination between strains [42,51] and (iii) the
Z5463PI and Z5463BC strains contain a second insertion of the
MDA phage that specifically insert in specific dRS3 repeats in
NIME sequences [20].
PCR were performed for each inconclusive sequence (sequence
lacking or discrepancy) using the two methods (454 and Solexa)
and sequenced using standard dye-terminator technology.
Primers used for these amplifications have been previously
described (Perrin et al., 2002). The sequence verifications were
done using the Big Dye Primer Sequencing Kit (Applied
Biosystems) and read on an ABI-Prism 310 automated sequencer
(Applied Biosystems).
Results
Duplication of the MDA prophage in the infecting strain
The week before becoming ill, the patient had been working
with a derivative of Z5463. Therefore, we first aimed at assessing
whether the strain isolated from the blood culture was a derivative
of Z5463. A PFGE analysis was performed (Fig. 1A) using material
obtained directly from the frozen stocks of Z5463, Z5463PI, the
isolate manipulated the week before the accident, and Z5463BC,
the isolate obtained directly from the blood culture of the patient.
Z5463PI had initially been selected from a colony of Z5463 for its
ability to produce high amounts of the MDA phage proteins on
colony immunoblots using an antibody against a peptide of
NMA1796, predicted to be the main capsid protein of the MDA
phage. Four passages took place between the frozen stock of
Z5463 and that of Z5463PI. All three strains have an identical
PFGE profile when digested by BglII (Fig. 1A), NheIo rSpeI (data
not shown). Furthermore, considering that Z5463PI had been
selected on the basis of the level of production of phage proteins, a
Southern-blot using an internal probe of the MDA phage was
performed on the BglII digested PFGE gel (Fig. 1B). This
experiment identified an additional occurence of the MDA
prophage in Z5463PI and Z5463BC chromosomes. The locations
of the MDA prophage in the chromosomes were mapped by LM-
PCR as described in the experimental procedure section. Both
strains had two copies of the MDA phage in the same places
(Fig. 1C). The first copy corresponded to the initial insertion of the
phage in dRS3 repeats localized between NMA1791 and
NMA1801 (gpm). The second phage copy was localised in dRS3
repeats localized between NMA1110 and NMA1111. The precise
location of this phage was found to be exactly the same in both
Figure 1. Identification of Z5463PI as the infectious strain. A- Pulsed-Field Gel Electrophoresis (PGFE) analysis using the enzyme BglII for DNA
digestions, revealed by ethidium bromide. B- Southern-blot on the PFGE gel using a probe against a MDA gene (NMA1792). The Southern-blot is
showing a second insertion of the MDA in Z5463PI and Z5463BC. M: molecular weight, 1: Z5463, 2: Z5463PI, 3: Z5463BC. C- Schematic presentation of
the different insertions of the MDA in Z5463PI and Z5463BC when compared to Z2491 and Z5463. 1. Locus of the wild type insertion of the MDA
(bases 1 737 566 to 1 742 107 of Z2491 genome), 2. Locus corresponding to the base 1 058 420 to 1 059 338 of Z2491, containing a second insertion
of the MDA in Z5463PI and Z5463BC in a dRS3 target sequence containing a dinucleotide CT at position 1058887 of Z2491 genome.
doi:10.1371/journal.pone.0017145.g001
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chromosome, in the middle of the dRS3 sequence. The flanking
regions of the phage occurrences sharing no homology, we
concluded for an active mechanism involved in the MDA phage
duplication. Altogether, these data demonstrate that the infecting
strain was Z5463PI, which has two copies of the MDA prophage
inserted in target dRS3 sequences.
Z5463 has a mutator phenotype
In order to get insights into the genomic changes that may be
associated with invasiveness, we undertook the sequencing of
Z5463 and its two derivatives Z5463PI and Z5463BC. Whole
genome sequencing was performed as described in the experi-
mental procedure section. Some inconclusive sequences were
found in the three genomes, due to frequent high homology
between some neisserial genes (opa for instance) and duplication of
some regions (mostly IS), and were further tested by PCR and
sequenced.
As already mentioned Z2491 and Z5463 were isolated in The
Gambia during the same epidemic and are therefore likely to
correspond to two isolates of the same clone. We first analyzed the
genomic differences between these two strains. The sequences and
verifications concluded that the overall organization of the two
genomes was the same. No large inversion, deletion or insertion
was present in Z5463 genome when compared to that of Z2491.
Differences between these two genomes are summarized in figure 2
and in Table S2. Four regions had numerous sequence differences
over a range of several open reading frames. One corresponded to
the pilin encoding locus with the expression site and the silent loci.
The other three regions are shown in more detail in figure 2.
Considering the ability of Neisseria to recombine with exogenous
DNA, these regions of high polymorphism could correspond to
recombination events that occurred following the uptake of DNA
of other Neisseria sharing the same niche as Z5463 or Z2491. In
addition to the high number of SNP detected in these regions, in
one of them a gene was inserted between NMA1950 (dhps) and
NMA1951. This gene has 99% sequence identity with the
phospho-2-dehydro-3-deoxyheptanoate aldolase (DAHP synthase)
genes NMW_0490 from Nm strain alpha275 (serogroup W135) and
NMV_0678 from Nm strain NMC8013 (serogroup C). All these
genes contain an AroA domain; we therefore named this new gene
aroA. This organisation, with an aroA homologue inserted just
before dhpS, is observed in several Nm strains (serogroup C 053442
and serogroup B MC58) as well as some Neisseria gonorrhoeae strains
(FCCP11945 and FA1090).
In addition to the above modifications, 87 localized differences
were present outside these 4 regions (Fig. 2, Table 1 and Table
S2). They corresponded to single nucleotide polymorphisms (SNP)
or small deletions or insertions. It should be pointed out that
numerous variations took place in repetitive sequences that have
Figure 2. Distribution of the genetic differences (SNP and insertions/deletions) between Z2491 and Z5463. Events are classified by
1 kb sequence with Z2491 genome as reference. Each event is represented as one coloured stretch according to the nature of the difference. The
three regions containing a high number of variations are highlighted: the differences are positioned on the corresponding genes represented as
white arrows. Variations in the pilin locus are excluded from this figure.
doi:10.1371/journal.pone.0017145.g002
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sequences were localized either in promoter regions or in open
reading frame sequences.
Excluding the pilin region, the number of genes that could
encode a protein with a different amino-acid sequence in Z5463
than in Z2491 is 64. In addition, 3 genes could have their
expression modified by a deletion/insertion in a phase variable
sequence in their promoter region. Table 2 summarizes the
functional groups to which the products of these genes belong.
Surprisingly, this analysis revealed the deletion of one bp at
position 2478 of the mutS gene of Z5463, introducing a stop codon
in the sequence, which would lead to the production of a truncated
MutS protein (Fig. 3A). In order to address the possibility that this
strain had a mutator phenotype, the ability of Z5463 to generate
mutants resistant to rifampicin was assessed. Z5463 has a rate of
mutations (10
27/generation) similar to that of a genetically
engineered mutS mutant (data not shown). The functional mutS
allele of Z2491 was then introduced into Z5463 as described in the
experimental procedure section, which reverse this hypermutator
phenotype (Fig. 3B), demonstrating that the high mutation rate
observed with Z5463 was indeed due to the defective mutS allele.
Analysis of the genotypic differences between Z5463PI
and Z5463BC
As for Z5463, the analysis of the sequence of Z5463PI and
Z5463BC did not reveal any major genomic rearrangement when
compared to that of Z2491, beside the additional insertion of the
MDA phage between NMA1110 and NMA1111. All the prophage
sequences were identical and similar to that of the parental strain
Z5463. Early hypothesis on the mechanism by which this
prophage may enhance invasiveness suggested that local genomic
rearrangements could occur especially around dRS3 repeats as a
consequence of the expression of phage proteins. Considering that
Z5463PI has been selected from Z5463 on the basis of the
expression of phage proteins on colony immunoblots, we wished to
test this hypothesis. Even though no genomic rearrangement had
been detected by sequencing, the organisation of all the sequences
surrounding dRS3 repeats, potential targets for the MDA phage,
Table 1. Number and classification of the genetic events having occured between each strain.
Z2491/Z5463 Z5463/Z5463PI Z5463PI/Z5463BC
deletion/insertion total 22 (21) 5 (5) 11 (11)
in open reading frame in phase variable region 13 (13) 2 (2) 9 (9)
other 6 (5) 1 (1) 1 (1)
in intergenic regions phase variable region in putative promoter 3 (3) 2 (2) 1 (1)
SNP total 474 (66) 35 (18) 23 (16)
in open reading frame without change in amino-acid sequence 276 (14) 14 (1) 8 (4)
with change for amino-acid of the same family 65 (15) 4 (3) 4 (3)
with change for amino-acid of a different family 86 (18) 6 (4) 10 (8)
in intergenic regions 47 (19) 11 (10) 1 (1)
Total 496 (87) 40 (23) 34 (27)
() changes outside zones of high number of repeat.
The pilin region was excluded from analysis.
doi:10.1371/journal.pone.0017145.t001
Table 2. Repartition of the genes under probable phenotypical variation.
total Z2491
comparison Z2491/
Z5463
comparison Z5463/
Z5463PI
comparison Z5463PI/
Z5463BC
Central/intermediary/misc metabolism
a 288
a 7
a 35
Conserved hypothetical 274 9 1 2*
Degradation of large molecules 34 2 1 0
Degradation of small molecules 22 1 0 0
Energy metabolism 96 1 0 3
Information transfer 233 5 0 0
Pathogenicity/Adaptation/Chaperonnes 96 9* 2 2
Phage/IS elements 186 8 1 0
Regulators 54 0 0 0
Surface (IM, OM, secreted…) 472 21* 5** 8
Unknown 237 4* 0 0
total 1992 67 13 20
aone of the gene, aroA, is inserted in Z5463 and its descendants but is absent from Z2491.
*one or ** two genes are submitted to phase variation due to a repeat region in their promoter region.
doi:10.1371/journal.pone.0017145.t002
Modifications of Meningococcus after Human Passage
PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e17145was confirmed using PCR and primers specific for each of these
sequences (see the experimental procedure section for details). All
sequences were amplified as expected according to the sequence of
Z5463, thus excluding the possibility that insertion, deletion or
inversion of sequences had occurred in Z5463PI and Z5463BC.
Unlike what has been observed between Z2491 and Z5463,
comparison of Z5463, Z5463PI and Z5463BC did not reveal
regions encompassing several ORFs with numerous sequence
differences except for the pilin locus that is subject to antigenic
variation (Fig. 4A and 4B). It should be pointed out that the pilE
gene of Z5463BC could not be directly sequenced. Indeed various
pilin variants were present in the DNA extracted directly from the
blood culture (see below). In addition, one major difference
between Z5463PI and Z5463BC was the deletion in Z5463BC of
lgtB (Fig. 4B). The lgtB gene is adjacent to lgtH in Z5463 and
Z5463PI and is predicted to encode a glycosyltransferase
implicated in the LOS biosynthesis. Both genes have highly
homologous 59 regions. It is likely that a recombination event took
place between these regions deleting the 39 region of lgtB, the
entire pseudogene lgtA’ and the 59 region of lgtH. This
recombination led to the total deletion of lgtB and lgtA’ and the
restoration of a full lgtH gene. All other genomic differences were
limited to SNP or deletions/insertion of less than 3 bp (Fig. 4,
Table 1 and Table S2). 40 sequence differences were present
between Z5463 and Z5463PI and 34 between Z5463PI and
Z5463BC.
We next focused on those genomic modifications with possible
phenotypic consequences, i.e. genes with a putative change in the
encoded amino-acid sequence or genes with a phase variable
promoter in which a phase variable event had occurred. Those
numbers of putative phenotypic modifications are limited since
respectively 11 proteins have a putative amino-acid sequence
difference in Z5463PI when compared to Z5463 and 19 in
Z5463BC versus Z5463PI. In addition two proteins have different
phase variable sequences in promoter regions between Z5463 and
Z5463PI and one between Z5463PI and Z5463BC. Table 2
summarizes the functional groups to which the products of these
genes belong. Both isolates, like the parental strain Z5463,
expressed an hypermutator phenotype due to a defective mutS
allele (Fig. 3B). It should be pointed out that the number of
changes in phase variable genes was higher between Z5463PI and
Z5463BC (10 of 34 differences, 30%) than between Z5463 and
Z5463PI (4 of 40 differences, 10%), thus pointing out the
importance of this mechanism for in vivo adaptation of Nm. The
list of the phase variable genes that have different sequences is
shown Table 3. The length of the repeats responsible for phase
variation of pilC and opa was variable amongst the colonies of
Z5463BC, thus pointing out that a bacterial population expressing
various phenotypes in these genes is probably needed to establish
infection.
Transcriptomic analysis
In order to get additional insights into modifications that could
be associated with virulence, we performed a transcriptomic
analysis looking for differences between Z5463 and Z5463PI on
one hand, and between Z5463PI and Z5463BC on the other
Figure 3. Hypermutator phenotype of Z5463, Z5463PI and Z5463BC. A- Schematic representation of the mutS gene of Z5463. The MutS
protein of Z5463 stops at position 844 (instead of 865 aa) due to 1 bp deletion in its gene sequence leading to an early stop codon (red stretch). B-
Frequency of appearance of mutants resistant to rifampicin for each of the different strains. The control strains correspond to the insertion of the
mutS allele of Z2491 (mutSZ2491) or Z5463 (mutSZ5463) in Z5463 mutS::Km, selected by the spectinomycin resistance cassette.
doi:10.1371/journal.pone.0017145.g003
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mental procedure section and each comparison was performed 3
times. The results of each independent experiment were pooled.
The only differences that were observed between Z5463 and
Z5463PI were the transcription of the MDA phage genes and one
gene, katA, encoding the catalase.
When comparing Z5463PI and Z5463BC, several differences
were observed (Table 4). Briefly, when compared to Z5463BC,
Z5463PI overexpressed some of the phage proteins. This
suggested that the isolate obtained from the bloodstream produced
less phage than Z5463PI; this is consistent with the fact that only
very small amount of circular DNA corresponding to the MDA
prophage could be detected in Z5463BC (data not shown). A
selection for bacterial cells not producing the MDA phage may
have occurred in vivo. Other genes differentially regulated between
the two isolates were the pseudogene dcmH encoding a
methyltransferase, pilT encoding the type IV pilus retraction
protein, pdxH encoding a pyridoxamine 59-phosphate oxidase
involved in vitamine B6 metabolic pathway and hypothetical
proteins or proteins without known function. In addition, hpuA,
encoding a haemoglobin receptor, and nalP, encoding an
autotransporter, are overexpressed in Z5463BC when compared
to Z5463PI. This is consistent with the sequencing results showing
these genes to be in ‘‘ON’’ phase in Z5463BC and in ‘‘OFF’’
phase Z5463 and Z5463PI.
Analysis of the phenotypic differences between Z5463PI
and Z5463BC
Considering the above genomic differences, we analysed in
more details the possible phenotypic consequences of (i) the loss of
lgtB, (ii) the change in the phase variable sequence of the
hemoglobin binding proteins and (iii) the heterogeneity in pilin
sequences.
The L9 immunotype lipooligosaccharide (LOS) structure of
Z2491 has previously been described [52] and is schematically
presented in figure 5A. According to the sequences and the
apparent size of their LOS (Fig. 5B), Z5463 and Z5463PI express
the same LOS as Z2491. On the other hand, Z5463BC expresses
a truncated LOS as seen in figure 5B. This result is consistent with
the absence of lgtB that adds a galactose on the terminal GlcNAc
of the LOS. LOS structure has been described to be important for
human serum resistance. We further tested the capacity of serum
resistance of Z5463BC by incubating the strain with 25% of
human serum. No differences were seen between Z5463BC and
Figure 4. Distribution of the genetic differences between Z5463, Z5463PI and Z5463BC. Events are classified by 1 kb sequence with
Z2491 genome as reference. Each event is represented as one coloured stretch according to the nature of the difference. The pilin region was
excluded from this figure. A- Genetic differences between Z5463PI and Z5463. The novel insertion of the MDA is annotated as one stretched as it
occurs at one specific position in the genome. B- Genetic differences between Z5463BC and Z5463PI. The region containing the deletion of lgtB gene
is highlighted.
doi:10.1371/journal.pone.0017145.g004
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from the patient (data not shown). The three strains grew normally
in these sera in contrast to a mutant lacking capsule which was
killed by complemented serum.
Among the differences in phase variable genes, we concentrated
on those important for iron acquisition in vivo. Nm can acquire iron
in vivo either via transferrin binding proteins TbpA and TbpB [53],
or via receptors specific for haemoglobin-haptoglobin [15,16,54].
Two sets of genes are required for the latter, hmbR on one hand
and hpuA/hpuB on the other hand. Surprisingly, hmbR is turned
OFF in Z5463BC (Fig. 6A), whereas the hpuA gene is ON (Fig. 6B)
which is the exact opposite of Z5463 and Z5463PI. To confirm
that these genotypic modifications were consistent with the
phenotype expressed by these variants, insertion mutants were
engineered by introducing the cat gene, conferring resistance to
chloramphenicol, in hpuA and the spectinomycin resistance
cassette in hmbR. The strains were then tested for their ability to
use human or bovine haemoglobin. As shown in figure 6C,
Z5463DhmbR cannot grow correctly on haemoglobin whereas
Z5463DhpuA has no growth defect. Z5463PI mutants had the
same phenotype (data not shown). In contrast, Z5463BCDhpuA
was unable to grow properly on haemoglobin unlike
Z5463BCDhmbR. Altogether these observations clearly confirm
that chelating iron from the haemoglobin/haptoglobin is impor-
tant for in vivo growth of Nm, and that during the in vivo passage the
HpuAB pathway has been selected in preference to the HmbR
pathway.
Considering that the pilin locus could not be sequenced due to
heterogeneity of the pilin variants expressed in the bacterial
population isolated from the bloodstream, eight colonies were
isolated from Z5463BC and the pilin locus of each of these isolated
colonies sequenced, thus identifying four different pilin variants.
Furthermore a PCR amplifying the pilin locus was performed on
Z5463BC without starting from an isolated colony and cloned in
E. coli, eight of these clones were sequenced, they identified an
additional two pilin variants in addition to the above four (Fig. 7).
In addition, a PCR was performed directly on a sample of the CSF
because no bacteria grew out of the CSF sample due to early
antibiotic administration. This PCR was cloned in E. coli and the
pilE gene sequenced from ten of these clones. Interestingly a single
pilin variant was present in the CSF, and this variant was different
from those isolated in the bloodstream.
Type IV pili is an essential bacterial attribute allowing
interaction of capsulated meningococci with endothelial cells.
Different pilin variants allow the bacteria to express different
phenotypes of bacterial-cell interaction. Among the four pilin
variants directly isolated from colonies of Z5463BC, one has a
non-piliated phenotype (Z5463BC2) and among the three other
sequences, two were identical at the protein level. The three
different derivatives were assessed for their ability to interact with
Table 3. Sequences subject to phase variation in one or more of the isolates.
gene Z2491 Frame Z5463 Frame Z5463PI Frame Z5463BC Frame References
NMA0048 pglA (G)14 in (G)11 in (G)9 out (G)10 out [24–27]
NMA0132 hypothetical (C)9 pro (C)9 pro (C)9 pro (C)8 pro [24,25]
NMA0277 hypothetical (A)11 pro (A)9 pro (A)10 pro (A)10 pro [24,27]
NMA0285/86 hydrolase (C)7 out (C)8 in (C)8 in (C)8 in [24]
NMA0293 pilC2 (G)11 out (G)10 out (G)10 out NUS - [24–26]
NMA0407 acetyltransferase (G)12 out (G)10 in (G)10 in (G)9 out [24,25]
NMA0475 hpuA (G)10 in (G)9 out (G)9 out (G)7 in [24,25]
NMA0478 nalP (C)10 in (C)9 out (C)9 out (C)10 in [24–27]
NMA0609 pilC1 (G)13 in (G)10 in (G)10 in NUS - [24,25,27]
NMA0619 wbpC (G)10 in (G)11 out (G)11 out (G)9 out [24,25,27]
NMA0641 conserved
hypothetical
CACTCCCT
(C)16
out CACTCCCT(C)9 in CACTCCCT(C)9 in CACTCCCT(C)9 in [24,25]
NMA0782 phage associated (C)7(N)10(G)7 in (C)6(N)10(G)7 out (C)6(N)10(G)7 out (C)6(N)10(G)7 out [24,27]
NMA0832 glycosyl-
transferase
(CAAACAA)
26(AT)3CTAT
in (CAAACAA)
14(AT)3CTAT
in (CAAACAA)
14(AT)3CTAT
in (CAAACAA)
14(AT)3CTAT
in [24]
NMA1090 conserved
hypothetical
(C)6 in (C)6 in (C)6 in (C)7 out [24]
NMA1251 opcA (C)17 pro (C)9 pro (C)9 pro (C)9 pro [24,25,27]
NMA1385 hsdM (A)8 dead (A)8 dead (A)9 dead (A)8 dead [24,27]
NMA1427 glycosyltransferase (G)9 out (G)9 out (G)9 out (G)10 in [24,25]
NMA1642 porA (G)12 pro (G)12 pro (G)11 pro (G)11 pro [24,25,27]
NMA1792 phage associated (C)10(N)10(G)7 pro (C)8(N)10(G)7 pro (C)8(N)10(G)7 pro (C)8(N)10(G)7 pro [24,25,27]
NMA1925 hmbR (G)10 out (G)11 in (G)11 in (G)9 out [24–27]
NMA2043 opaA (CTTCT)11 out (CTTCT)10 out (CTTCT)10 out NUS - [24,25]
out: non functional protein;
in: functional protein;
pro: phase variation in the promoter region;
dead: stop codon in the three reading frames.
NUS: No Unique Sequence.
doi:10.1371/journal.pone.0017145.t003
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adhered to human brain microvessel endothelial cells (hCMEC/
D3) and induced the recruitment of focal adhesion plaques with an
index of recruitment superior to 95% (Fig. 8 B; data not shown).
No major difference was observed between these variants except
that they had varying abilities to form microcolonies onto the
apical surface of the cells.
Discussion
This work describes the characterization of a laboratory strain
causing meningitis in a previously healthy research worker. The
knowledge of events leading to the disease allowed us to assess the
number of bacterial division that occurred in vivo. We hypothezised
that the number of SNP between Z5463 and Z5463PI per
generation that has occurred between Z5463 and Z5463PI was
identical to the number of SNP between Z5463PI and Z5463BC
per generation between Z5463PI and Z5463BC. The number of
generations between Z5463PI and Z5463BC corresponds to the
number of generation in vivo and in the blood culture flask. We
could approximate the latter by knowing the time it took for the
flask to be detected as positive in the clinical microbiology
laboratory and determining the doubling time of Nm in these
flasks. The number of generation between Z5463 and Z5463PI
was approximated knowing the number of in vitro passages that
had been performed. According to the above, the number of
bacterial generations in vivo is roughly 25. This number is only an
approximation as it implies that the frequency of SNP between
strains passed on plate or in human remain the same and is
directly dependent on the number of bacterial generations.
Surprisingly, the number of in vivo generations remains limited.
The high number of SNP and phase variation detected in the
descendants of Z5463 (calculated mutation rate of about 10
27 per
generation, data not shown) even with few generations is in
accordance with its hypermutator phenotype due to a non-
functional MutS protein [55]. Several serogroup A strains isolated
Table 4. Trancriptomic analysis of Z5463PI versus Z5463BC.
Genes Function PI BC
NMA0127 rplW, 50S ribosomal protein L23 2.4
NMA0193 dcmH, cytosine-specific methyltransferase
(pseudogene)
2.9
NMA0218 pilT, type IV pilus retraction ATPase PilT 2.2
NMA0246 gapB, glyceraldehyde-3-phosphate dehydrogenase B 2.6
NMA0256 putative BolA-like protein 2.8
NMA0326 pyrH, uridylate kinase 3
NMA0328 rspB, 30S ribosomal protein S2 3.36
NMA0475 hpuA, haemoglobin-haptoglobin utilization lipoprotein
A
4.7
NMA0478 nalP, autotransported serine protease NalP 2.2
NMA0737 hypothetical membrane-associated protein 3.9
NMA0738 putative transcriptional regulator 2.9
NMA0793 trmD, tRNA (guanine-N(1)-)-methyltransferase 2.6
NMA1060 dcd, deoxycytidine triphosphate deaminase 2.8
NMA1572 pdxH, pyridoxamine 59-phosphate oxidase 3
NMA1577 conserved hypothetical protein 4.8
NEIMA1749 H.8-like outer-membrane lipoprotein 2.8
NMA1792 putative phage replication initiation factor 7.9
NMA1795 hypothetical integral membrane protein 11.8
NMA1837 putative peptidase 3.2
The numbers correspond to the fold change upregulation (average on three
experiments in swap-dye) in Z5463PI when compared to Z5463BC (column PI)
and in Z5463BC when compared to Z5463PI (column BC). Only the genes
upregulated by more than 2-fold in at least half the experiments are mentioned
here.
doi:10.1371/journal.pone.0017145.t004
Figure 5. LOS variation analysis of the strain isolated from the blood culture. A- Schematic representation of the immunotype L9 LOS of
serogroup A Nm Z2491 (adapted from Zhu and coworkers [68] and Choudhury and coworkers [52]). The deletion of the lgtB gene in Z5463BC is
predicted to form a truncated LOS lacking the galactose on the terminal GlcNAc. B- Decreased size of the LOS from Z5463BC due to the loss of lgtB.
Tricine SDS-PAGE gel of proteinase K LOS extracts from Z5463BC and its parental strains, revealed by silver staining. 1: Z2491 (L9 immunotype), 2:
Z5463, 3: Z5463PI, 4: Z5463BC.
doi:10.1371/journal.pone.0017145.g005
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tator phenotype [31,55], a functional MutS or MutL can
complement some of these mutations. The three strains, Z5463,
Z5463PI and Z5463BC, contain a mutated allele conferring a
non-functionnal MutS. Nevertheless we detected more differences
in phase variable genes during the in vivo passage than in vitro
(respectively 30% and 10% of the total differences). Interestingly,
most of the proteins subject to phase variation between the three
strains are related to virulence. For instance, the NalP protein [56]
is expressed in Z5463BC but not in Z5463 and Z5463PI. This
autotransporteur modulates the secretion of itself, App and IgA
protease [57] as well as LbpB [58] and is therefore believed to be
important for virulence. Furthermore, different antibodies against
these proteins are found in patient sera [59], their release could
help to escape the host immune system. Other surface components
are indirectly affected, the pglA gene is OFF in Z5463BC
preventing the glycosylation of pilin on serine 63, which is not
the case in the parental strains; this change would not affect
piliation or adhesion to human cell [60] but can confer an
advantage to the bacteria to escape the immune system.
Furthermore, hmbR is turned OFF in Z5463BC, whereas hpuA is
ON which is the opposite of Z5463 and Z5463PI. We investigated
the haemoglobin utilisation systems in Z5463BC and showed that
both HmbR and HpuA were functional when in the ‘‘ON’’ phase.
This switch between the haemoglobin receptors may be a means
to escape the host defences because of the presence in the patient
blood of antibodies directed against HmbR. Unfortunately, we
were unable to test the presence of specific antibodies in the
patient blood directly after the infection.
It appears that the hypermutator phenotype due to the MutS
protein confers sequence variations highly impacted in vivo by the
selective pressure imposed by the host immune system. This was
expected as the infecting strain is a derivative of an epidemic clone
and therefore can be considered as having all the necessary
attributes to be potentially fully adapted and virulent to its host.
For instance, Z5463 and Z5463PI both possess a functional
haemoglobin utilisation system, but each human individual has a
different and evolving immune system repertoire, which imposes a
high selective pressure on the bacteria.
For some phase (opa, pilC) and antigenic (pilin) variable genes,
we obtained various sequences in the blood isolate. This apparent
polymorphism of bloodstream strains has previously been
documented in patients for opa and pilin expression [61]. The
pilE gene from Z5463PI was identical to that of Z5463 showing no
selection in vitro. One of the six different pilE variants of Z5463BC
shared the same sequence as Z5463. The other variants were
certainly due to recombination with different pilS sequences of
Z5463. We were unable to find the CSF pilin variant among the
different variants we isolated from the blood culture. Similar
results on pilin variation during in vivo studies have already been
observed for N. gonorrhoeae. Gonococcal pilin antigenic variation
has been shown in vitro [62] and in vivo by studying the piliation
state of bacteria infecting the same family or by following infection
in volunteers [63]. These studies showed the higher rate of switch
in vivo when compared to in vitro [63]. The presence of a pool of
bacteria in the patient blood could increase the ability of the
bacteria to invade and survive in its host.
Surprisingly, no recombination events could be detected in
Z5463PI or Z5463BC despite the presence of a second MDA
prophage in their genome. A recent epidemiological study had
demonstrated that the presence of the prophage was associated with
increased invasiveness in adolescents [21]. The phage does not
encode anyknown virulencefactorsand deletion of the entire phage
was without effect in several laboratory models of meningococcal
pathogenesis[20].Thisphageisalwaysinsertedintosmallrepeatsof
the meningococcal genome, designated dRS3. This suggests that
some phage proteins have the ability to recognize these sequences.
In addition, one of its proteins (the product of NMA1800) has
Figure 6. Ability of the blood culture strain to use human and bovine haemoglobin. A- Sequences and alignment of the HmbR protein.
12G in Z5463BC lead to a full-length protein; 10G in Z5463 and Z5463PI is responsible for a stop codon at aa 396. B- Sequences and alignment of the
HpuA protein. 10C in Z2491, Z5463 and Z5463PI lead to a full-length protein; 9C in Z5463BC is responsible for a stop codon at aa 23). C- Growth in
iron depleted medium and supplemented with disks containing human or bovine haemoglobin.
doi:10.1371/journal.pone.0017145.g006
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hypothesis regarding the role of this phage is that, when expressed,
some of its proteins could promote genomic rearrangements with
possible phenotypic consequences, especially on invasiveness
[20,51,64]. The fact that a duplication of the prophage had
occurred while selecting for isolates producing high amount of
phage proteins, reinforced this hypothesis. This duplication is
restricted to the phage, the sequences on each side of the two
insertions do not have any homology, thus demonstrating that the
element is active and capable of reintegrating itself in Nm genome.
This duplication of the MDA was stable upon passages (the MDA
being exactly in same location between Z5463PI and Z5463BC) but
was not associated with genome rearrangement.
The differences observed in the bloodstream strain (SNP, phase
variation and localised recombination of single genes) have been
selected over a very short period of time. A larger number of
generation elapsed between the clones (isolated in different
patients) lead to a predominance of recombination events as
between Z2491 and Z5463 that were isolated from the same
epidemics at the same time.
A surprising result was the deletion of lgtB, which is involved in
lipooligosaccharide synthesis [65]. Z2491 expresses a well-
described L9 immunotype LOS [52], as do Z5463 and
Z5463PI. Z5463BC expresses a truncated LOS and we can
assume that this changes its immunoreactivity. All isolates were
resistant to complemented commercial sera and to the patient sera
(sampled 2 years post infection). A truncated L3-immunotype LOS
lacking the terminal galactose, due to the deletion of lgtB, still
produces a bactericidal antibody response in mice similarly to the
wild type non-truncated LOS [66]. Furthermore, these antibodies
react with LOS but not with lacto-N-neotetraose as do antibodies
elicited by the wild-type strain. It is possible that the recombina-
tion between lgtB and lgtH has been selected due to the presence in
the patient blood of antibodies specific for the terminal structure of
the LOS.
To conclude, this study shows that the sequence variations in
vivo, occurring during a limited number of bacterial generations,
give rise to important phenotypic changes in the bacteria and have
a direct impact on the adaptation of the bacteria to its host. This
illustrates perfectly the potential of Nm to adapt its repertoire of
Figure 7. Sequences of the various pilin variants isolated in vivo. Several sequences were isolated from the blood culture in contrast to the
only variant isolated from its parental strains passed in vitro. The alignment of the different pilE sequences shows 4 different variants of the PilE
protein found in the blood culture and differing from the one found in the CSF of the patient. Sequence alignments of full-length prepilin are shown
with highlights on structural features (inspired by Craig and corworkers [69]).
doi:10.1371/journal.pone.0017145.g007
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system and increasing its virulent in a new host [67].
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